Table 2

Intrinsic Validity and Likelihood Ratios of Laryngeal Height, Lung Function Questionnaire, and COPD Diagnostic Questionnaire

MeasurementSensitivity % (CI 95%)Specificity % (CI 95%)LR+ (95% CI)LR– (95% CI)
LH21 (0–43)96 9(3–99)5.21 (1.59–17.14)0.82 (0.62–1.08)
LHa18 (5–41)96 (94–99)4.98 (1.2–20.72)0.85 (0.64–1.12)
LFQ93 (79–106)71 (65–77)3.18 (0.65–4.09)0.10 (0.02–0.67)
LFQa91 (74–108)70 (65–77)3.11 (2.36–4.11)0.13 (0.02–0.83)
COPD DQ36 (11–61)93 (89–96)4.89 (2.1–11.4)0.69 (0.47–1.03)
COPD DQa18 (5–41)93 (89–96)2.49 (0.62–9.5)0.88 (0.67–0.17)
LH + LFQ75 (33–117)97 (95–100)29.06 (9.48–89.13)0.26 (0.05–1.4)
  • COPD = chronic obstructive pulmonary disease ; DQ = diagnostic questionnaire; FEC = forced vital capacity; FEV1 = forced expiratory volume in 1 second;LFQ = Lung Function Questionnaire; LH = laryngeal height; LR− = negative likelihood ratio; LR+ = positive likelihood ratio.

  • a Excluding patients with previously diagnosed COPD (FEV1/FVC) <0.7.